Thalidomide teratogenesis: evidence for a toxic arene oxide metabolite.
It was postulated that thalidomide causes birth defects by being metabolized to a toxic electrophilic intermediate. This hypothesis was tested by using an in vitro assay in which drug toxicity to human lymphocytes was assessed in the presence of a hepatic microsomal drug metabolizing system. Maternal hepatic microsomes from pregnant rabbits mediated the production of a metabolite that was toxic to lymphocytes. Toxicity was enhanced by inhibitors of epoxide hydrolase (EC 3.3.2.3) and abolished by adding the purified enzyme to the incubation medium. The metabolite thus appears to be in arene oxide, consistent with the previously reported isolation of phenolic metabolites of thalidomide from the urine of treated animals. Two teratogenic analogs of thalidomide (phthalimidophthalimide and phthalimidinoglutarimide) were also toxic in the system; two nonteratogenic analogs (phthalimide and hexahydrothalidomide) were not toxic, even in the presence of epoxide hydrolase inhibitors. The toxic metabolite of thalidomide was not produced by rat liver microsomes (the rat is not sensitive to thalidomide teratogenesis) but was produced by hepatic preparations from maternal rabbits, and rabbit, monkey, and human (all sensitive species) fetuses. A toxic arene oxide therefore may be involved in the teratogenicity of thalidomide.
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000818:Animals; D001711:Biotransformation; D004305:Dose-Response Relationship, Drug; D004851:Epoxide Hydrolases / Q000378:metabolism; D004852:Epoxy Compounds / Q000378:metabolism* / Q000633:toxicity; D004988:Ethers, Cyclic / Q000378:metabolism*; D005260:Female; D006801:Humans; D008099:Liver / Q000196:embryology; D008214:Lymphocytes / Q000187:drug effects; D008862:Microsomes, Liver / Q000378:metabolism; D011817:Rabbits; D051381:Rats; D013045:Species Specificity; D013329:Structure-Activity Relationship; D013792:Thalidomide / Q000378:metabolism*
D004852:Epoxy Compounds; D004988:Ethers, Cyclic; D013792:Thalidomide; D004851:Epoxide Hydrolases